Holen Sie sich die Stockscreener-App
15.50
5.30%
0.78
Handel nachbörslich:
15.50
Schlusskurs vom Vortag:
$14.72
Offen:
$14.9
24-Stunden-Volumen:
837.13K
Relative Volume:
0.98
Marktkapitalisierung:
$1.35B
Einnahmen:
$2.01B
Nettoeinkommen (Verlust:
$-253.84M
KGV:
-5.0654
EPS:
-3.06
Netto-Cashflow:
$115.19M
1W Leistung:
+7.34%
1M Leistung:
+18.14%
6M Leistung:
+7.12%
1J Leistung:
+53.31%
1-Tages-Spanne:
$14.75
$15.63
1-Wochen-Bereich:
$14.04
$15.63
52-Wochen-Spanne:
$9.83
$17.67
Pediatrix Medical Group Inc Stock (MD) Company Profile
Firmenname
Pediatrix Medical Group Inc
Sektor
Branche
Telefon
(954) 384-0175
Adresse
1301 CONCORD TERRACE, SUNRISE, FL
Vergleichen Sie MD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MD
Pediatrix Medical Group Inc
|
15.50 | 1.28B | 2.01B | -253.84M | 115.19M | -3.06 |
|
HCA
Hca Healthcare Inc
|
390.46 | 91.33B | 72.70B | 6.88B | 7.29B | 23.79 |
|
THC
Tenet Healthcare Corp
|
171.87 | 15.06B | 20.52B | 1.46B | 1.41B | 15.12 |
|
FMS
Fresenius Medical Care Ag Adr
|
24.84 | 14.20B | 20.92B | 666.06M | 1.85B | 1.1422 |
|
EHC
Encompass Health Corp
|
119.13 | 11.95B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
178.51 | 11.15B | 16.08B | 1.20B | 1.06B | 17.82 |
Pediatrix Medical Group Inc Stock (MD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-16 | Eingeleitet | Macquarie | Outperform |
| 2024-09-26 | Hochstufung | Jefferies | Hold → Buy |
| 2024-06-07 | Hochstufung | Deutsche Bank | Sell → Hold |
| 2021-09-27 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-06-23 | Fortgesetzt | Stifel | Hold |
| 2020-10-19 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2020-01-03 | Herabstufung | Citigroup | Buy → Neutral |
| 2019-12-12 | Hochstufung | Stifel | Hold → Buy |
| 2019-09-06 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-01-15 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Hold |
| 2018-11-16 | Eingeleitet | UBS | Sell |
| 2018-09-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-09-18 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2018-08-03 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-07-12 | Eingeleitet | Leerink Partners | Mkt Perform |
| 2018-03-27 | Eingeleitet | Credit Suisse | Neutral |
| 2018-02-12 | Bestätigt | Mizuho | Neutral |
| 2017-12-13 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-09-18 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2017-05-30 | Bestätigt | Mizuho | Neutral |
| 2017-05-25 | Bestätigt | Stifel | Hold |
| 2017-05-04 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2017-03-21 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2017-03-10 | Herabstufung | JP Morgan | Overweight → Neutral |
Alle ansehen
Pediatrix Medical Group Inc Aktie (MD) Neueste Nachrichten
Astrana Health, agilon health, Guardant Health, AdaptHealth, and Pediatrix Medical Group Stocks Trade Up, What You Need To Know - TradingView
Pediatrix Medical Group’s Q2 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Inflation Eases, Stocks Rally: Thermo Fisher, ICU Medical, CONMED, Pediatrix Medical Group, and IQVIA See Gains - AInvest
Thermo Fisher, ICU Medical, CONMED, Pediatrix Medical Group, and IQVIA Stocks Trade Up, What You Need To Know - TradingView
Here's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock - Yahoo Finance
Pediatrix Medical Group's Q2 Earnings Surge: A Blueprint for Strategic Resilience in a Shifting Healthcare Landscape - AInvest
Pediatrix Medical's Q2 Earnings Beat on Strong Patient Volumes - Zacks Investment Research
Pediatrix Medical Group, Inc. Just Beat EPS By 24%: Here's What Analysts Think Will Happen Next - Yahoo Finance
Pediatrix Medical Group Exceeds Q2 Forecasts, Raises Full-Year Adjusted EBITDA Outlook - AInvest
Jefferies lowers Pediatrix Medical Group stock price target to $19 on eAPTC concerns - Investing.com Canada
Pediatrix Medical Group Breaks Above 200-Day Moving AverageBullish for MD - Nasdaq
Pediatrix Medical Group, Inc. (NYSE:MD) Q2 2025 Earnings Call Transcript - Insider Monkey
Deutsche Bank Adjusts Pediatrix Medical Group Price Target to $13 From $15, Maintains Hold Rating - MarketScreener
Pediatrix raises 2025 adjusted EBITDA guidance to $245M–$255M as NICU days climb 6% and cash flow strengthens - MSN
Pediatrix Medical Group: Q2 Earnings Snapshot - New Haven Register
Pediatrix Medical Group Inc (MD) (Q2 2025) Earnings Call Highlights: Strong EBITDA and Cash ... By GuruFocus - Investing.com Canada
Pediatrix Medical Group Inc (MD) (Q2 2025) Earnings Call Highlig - GuruFocus
Pediatrix (MD) Q2 EPS Jumps 56% - AOL.com
Decoding Pediatrix Medical Group Inc (MD): A Strategic SWOT Insi - GuruFocus
Pediatrix (MD) Q2 EPS Jumps 56% - The Motley Fool
Earnings call transcript: Pediatrix Medical Q2 2025 beats EPS forecast - Investing.com India
Earnings call transcript: Pediatrix Medical Q2 2025 beats EPS forecast By Investing.com - Investing.com Australia
Pediatrix Medical Group (MD) Appoints Kurt D. Newman to Board - Insider Monkey
Is Pediatrix Medical Group (MD) Poised for a Recovery in Women's Health and Neonatal Care? - AInvest
Pediatrix Medical Group's Q2 2025: Key Contradictions in Admin Fees, Growth Expectations, and Buyback Strategies - AInvest
Pediatrix Medical Group Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Order Book Volume Tilts Bullish on Pediatrix Medical Group Inc.Accurate Buy Point for Momentum Stocks Detected - beatles.ru
Pediatrix Medical Group (MD) Q2 Earnings and Revenues Top Estimates - sharewise.com
Pediatrix Medical Group’s (NYSE:MD) Q2 Sales Beat Estimates - Yahoo Finance
Pediatrix Medical Group Inc Surpasses Q2 2025 Estimates with EPS of $0.46 and Revenue of $469 Million - GuruFocus
Pediatrix Medical Group tops Q2 expectations, raises 2025 outlook By Investing.com - Investing.com Australia
Pediatrix Medical reports Q2 adjusted EPS 53c, consensus 42c - TipRanks
Pediatrix Medical (MD) Projects FY25 Adjusted EBITDA Between $245M and $255M - GuruFocus
Pediatrix Medical Group Raises Outlook After Strong Quarter - Finimize
Pediatrix Medical (MD) Exceeds Revenue Expectations and Raises 2025 EBITDA Outlook - GuruFocus
Pediatrix Medical Group tops Q2 expectations, raises 2025 outlook - Investing.com
Pediatrix Medical (MD) Exceeds Revenue Expectations and Raises 2 - GuruFocus
Pediatrix Medical (MD) Projects FY25 Adjusted EBITDA Between $24 - GuruFocus
Pediatrix Medical Group Reports Second Quarter Results | MD Stock News - GuruFocus
Physician services firm Pediatrix beats Q2 revenue estimates, raises 2025 EBITDA outlook - MarketScreener
Earnings Flash (MD) Pediatrix Medical Group, Inc. Reports Q2 Revenue $468.8M, vs. FactSet Est of $464.4M - MarketScreener
Earnings Flash (MD) Pediatrix Medical Group, Inc. Posts Q2 Adjusted EPS $0.53 per Share, vs. FactSet Est of $0.42 - MarketScreener
Pediatrix Medical Group Reports Second Quarter Results - Enidnews.com
Pediatrix Q2 2025 Earnings: Adjusted EBITDA Raises to $245M-$255M - AInvest
Earnings To Watch: Pediatrix Medical Group (MD) Reports Q2 Results Tomorrow - Yahoo Finance
Is Pediatrix Medical Group Inc. a good long term investmentMarket-crushing profits - Jammu Links News
What institutional investors are buying Pediatrix Medical Group Inc. stockDiscover breakthrough stocks with expert help - Jammu Links News
What catalysts could drive Pediatrix Medical Group Inc. stock higher in 2025Capitalize on fast-growing stocks today - Jammu Links News
How many analysts rate Pediatrix Medical Group Inc. as a “Buy”Consistently outstanding ROI - Jammu Links News
What is Pediatrix Medical Group Inc. company’s growth strategyRealize consistent double-digit growth - Jammu Links News
Why is Pediatrix Medical Group Inc. stock attracting strong analyst attentionMaximize returns with strategic portfolio planning - Jammu Links News
Finanzdaten der Pediatrix Medical Group Inc-Aktie (MD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.03%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):